logo

Steven Gore, MD

Steven Gore, MD

Oncology Baltimore, MD

Professor, Oncology, Johns Hopkins University School of Medicine

Office Address

Office Map
  • 600 N Wolfe St
    Baltimore, MD 21287
    Phone: (410) 955-8964

Dr. Gore's Clinical Specialties & Interests

  • Oncology: General Oncology

Dr. Gore's Education & Medical Training

  • Johns Hopkins UniversityJohns Hopkins UniversityFellowship, Medical Oncology
  • University of ChicagoUniversity of ChicagoResidency, Internal Medicine
  • Yale Univ Sch of MedYale University School of MedicineMedical School

Dr. Gore's Certifications & Licensure

  • CT State Medical LicenseCT State Medical License2013 - 2014
  • MD State Medical LicenseMD State Medical License1987 - 2014
  • American Board of Internal MedicineAmerican Board of Internal MedicineInternal Medicine
  • American Board of Internal MedicineAmerican Board of Internal MedicineMedical Oncology

Dr. Gore's Awards, Honors, & Recognition

  • SuperDoctors.comSuper DoctorSuperDoctors.com

Dr. Gore's Clinical Trials

Dr. Gore's Publications & Presentations

PubMed | Citations by Web of Science®

Grant Support

  • Mechanism Of Combined 'Epigenetic Therapy'In Myeloid Malignancies
    Mechanism Of Combined 'Epigenetic Therapy'In Myeloid MalignanciesNational Cancer Institute
    2007 - 2009
  • Targeting Epigenomics In Myeloid Neoplasms
    Targeting Epigenomics In Myeloid NeoplasmsNational Cancer Institute
    2005 - 2011
  • Arsenic Trioxide In Primary Curative APL Therapy
    Arsenic Trioxide In Primary Curative APL TherapyNational Cancer Institute
    2004 - 2008
  • 5-Azacytidine And MS-275 In Myeloid Malignancies
    5-Azacytidine And MS-275 In Myeloid MalignanciesNational Cancer Institute
    2004 - 2005
  • DNA Methyltransferase/Histone Deacetylase Inhibition
    DNA Methyltransferase/Histone Deacetylase InhibitionNational Cancer Institute
    2000 - 2002
  • Clinical Histone Deacetylase Inhibition And Retinoids
    Clinical Histone Deacetylase Inhibition And RetinoidsNational Cancer Institute
    2000 - 2001
  • Phase I Trial Of Sodium Phenylbutyrate (EL532) In Myelodysplastic Patients
    Phase I Trial Of Sodium Phenylbutyrate (EL532) In Myelodysplastic PatientsNational Center For Research Resources
    1997 - 1997
  • Butyric Acid Derivatives In Myeloid Malignancies
    Butyric Acid Derivatives In Myeloid MalignanciesNational Cancer Institute
    1995 - 1999

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • BCBS California CaliforniaCare HMO
  • BCBS California PowerSelect HMO
  • BCBS California PPO
  • Blue Shield CA Local Access Plus HMO
  • Blue Shield California HMO
  • Blue Shield California PPO
  • CareFirst BCBS Maryland POS
  • CareFirst BlueChoice Advantage
  • CareFirst BlueChoice Network POS
  • CareFirst BluePreferred PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • Great West PPO
  • Health Net California Large Group PPO
  • Health Net HMO - Employer Group
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • Pacificare HMO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Alternate Names

  • Dr. Steven Gore, Dr. Steven Gore, MD, Dr. S Gore, Dr. Steven David Gore

15 Colleague Invites!
Is this you? If so, register to see 15 messages.

Physicians, view Dr. Gore's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV